IDEXX LABORATORIESIDEXX LABORATORIESIDEXX LABORATORIES

IDEXX LABORATORIES

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
2.43CHF
Revenue estimate
‪871.03 M‬CHF
Market capitalization
‪37.89 B‬CHF
‪711.47 M‬CHF
‪3.08 B‬CHF
‪82.27 M‬
Beta (1Y)
1.78

About IDEXX Laboratories, Inc.

CEO
Jonathan J. Mazelsky
Website
Headquarters
Westbrook
Employees (FY)
‪11 K‬
Founded
1983
FIGI
BBG00LVDKYW8
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of IX1 is 467.540 CHF — it has increased by 9.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange IDEXX LABORATORIES stocks are traded under the ticker IX1.
IDEXX LABORATORIES is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
IX1 stock is 8.80% volatile and has beta coefficient of 1.78. Check out the list of the most volatile stocks — is IDEXX LABORATORIES there?
IX1 earnings for the last quarter are 2.32 CHF per share, whereas the estimation was 2.17 CHF resulting in a 6.72% surprise. The estimated earnings for the next quarter are 1.79 CHF per share. See more details about IDEXX LABORATORIES earnings.
IDEXX LABORATORIES revenue for the last quarter amounts to ‪838.16 M‬ CHF despite the estimated figure of ‪848.56 M‬ CHF. In the next quarter revenue is expected to reach ‪750.90 M‬ CHF.
Yes, you can track IDEXX LABORATORIES financials in yearly and quarterly reports right on TradingView.
IX1 net income for the last quarter is ‪163.77 M‬ CHF, while the quarter before that showed ‪194.30 M‬ CHF of net income which accounts for −15.71% change. Track more IDEXX LABORATORIES financial stats to get the full picture.
Today IDEXX LABORATORIES has the market capitalization of ‪37.89 B‬, it has decreased by 2.81% over the last week.
No, IX1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IX1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IDEXX LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.
IX1 reached its all-time high on Jul 29, 2021 with the price of 634.346 CHF, and its all-time low was 408.456 CHF and was reached on Sep 14, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 28, 2024, the company has ‪11.00 K‬ employees. See our rating of the largest employees — is IDEXX LABORATORIES on this list?
We've gathered analysts' opinions on IDEXX LABORATORIES future price: according to them, IX1 price has a max estimate of 614.81 CHF and a min estimate of 519.17 CHF. Read a more detailed IDEXX LABORATORIES forecast: see what analysts think of IDEXX LABORATORIES and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IDEXX LABORATORIES EBITDA is ‪1.02 B‬ CHF, and current EBITDA margin is 32.98%. See more stats in IDEXX LABORATORIES financial statements.